Actively Recruiting
Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
Led by University of Aarhus · Updated on 2025-09-08
90
Participants Needed
1
Research Sites
92 weeks
Total Duration
On this page
Sponsors
U
University of Aarhus
Lead Sponsor
U
University of Southern Denmark
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study investigates whether vaginal estrogen treatment has an effect on hemostatic parameters in postmenopausal women. Blood samples are collected before and after 3 months treatment to assess changes in hemostasis.
CONDITIONS
Official Title
Vaginal Estrogen Treatment and Effect on Hemostatic Parameters in Postmenopausal Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Postmenopausal women aged 50 or older
- Having symptoms of vaginal atrophy
- Indicated for treatment with vaginal estrogen tablets 10 micrograms at least three times a week
- Study population 1: without history of venous thromboembolic event
- Study population 2: with history of venous thromboembolic event
You will not qualify if you...
- Unable to provide written informed consent
- Does not speak Danish
- Currently receiving cancer treatment
- Currently using blood thinning medication (except platelet inhibitors)
- Currently using local or systemic estrogen treatment
- Having systemic inflammatory disease, liver disease, or kidney disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Obstetrics and Gynecology, Aarhus University Hospital, Denmark
Aarhus N, Denmark, 8200
Actively Recruiting
Research Team
P
Pinar Bor, Pinar Bor, MD, PhD, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here